Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer

NCT01227772 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01227772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2010
Completion date
June 30, 2017
Enrollment
23 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer